MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer

Abstract

MiR-661 promotes metastasis of NSCLC through RB/E2F1 signaling and EMT events, thus may serves as a negative prognostic factor and possible target for treatment of NSCLC patient.